Cellular effects of HER3-specific affibody molecules.
Recent studies have led to the recognition of the epidermal growth factor receptor HER3 as a key player in cancer, and consequently this receptor has gained increased interest as a target for cancer therapy. We have previously generated several Affibody molecules with subnanomolar affinity for the H...
Main Authors: | Lovisa Göstring, Magdalena Malm, Ingmarie Höidén-Guthenberg, Fredrik Y Frejd, Stefan Ståhl, John Löfblom, Lars Gedda |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3386944?pdf=render |
Similar Items
-
Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification.
by: Magdalena Malm, et al.
Published: (2013-01-01) -
Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification.
by: Magdalena Malm, et al.
Published: (2013-01-01) -
Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis
by: Susanne Klint, et al.
Published: (2023-12-01) -
The HER2-binding affibody molecule (Z(HER2∶342))₂ increases radiosensitivity in SKBR-3 cells.
by: Lina Ekerljung, et al.
Published: (2012-01-01) -
Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
by: Allal Boutajangout, et al.
Published: (2019-03-01)